Ma Aixia(left-3),Yu Guancong(left-2),Fang Fang(left-5),Ding Jinxi(left-4),Chang Feng(left-1)

  Ma Aixia, dean of School of International Pharmaceutical Business of China Pharmaceutical University, Ph.D., professor, doctoral advisor of pharmacoeconomics of China Pharmaceutical University, member of Specialized Committee of Pharmacoeconomics of Chinese Pharmaceutical Association, standing director of Association of Health Economics of Jiangsu Province, member of expert panel of Pharmacoeconomic Assessment Criteria under “National List of Essential Medicine (NLEM)”.
  Yu Guancong, Mongolian Nationality, secretary of Committee of Communist Party of China of School of International Pharmaceutical Business of China Pharmaceutical University, doctor candidate, associate researcher.
  Fang Fang, vice secretary of Committee of Communist Party of China of School of International Pharmaceutical Business of China Pharmaceutical University, MBA of Naning University, visiting scholar of University of Reading, UK.
  Ding Jinxi, Ph.D., professor, part-time lawyer, doctoral advisor of Social and Administrative Pharmacy of China Pharmaceutical University, vice dean of School of International Pharmaceutical Business of China Pharmaceutical University.
  Chang Feng, Ph.D., associate professor, vice dean of School of International Pharmaceutical Business of China Pharmaceutical University, researcher of The Research Center of National Drug Policy & Ecosystem (NDPE) of China Pharmaceutical University, member of Program of Young and Middle-Aged Academic Leaders under Qing Lan Project of Jiangsu Province, visiting scholar of University of Cincinnati, USA.